Warfarin treatment quality and outcomes in patients with non-valvular atrial fibrillation and CKD G3-G5D

Warfarin treatment quality is calculated as time in therapeutic range (TTR). TTR  ≥ 70 % is considered reducing the risk of adverse events for patients with atrial fibrillation (AF). The association of TTR and adverse events in chronic kidney disease (CKD) is however poorly investigated. The aim is to explore this further.

Source: Thrombosis Research - July 7, 2023 Category: Hematology Authors: Frida Welander, Henrik Renlund, Em öke Dimény, Henrik Holmberg, Anders Själander Tags: Full Length Article Source Type: research